Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007381
Filing Date
2022-05-05
Accepted
2022-05-05 16:16:07
Documents
79
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20220331x10q.htm   iXBRL 10-Q 1926626
2 EX-10.1 knsa-20220331xex10d1.htm EX-10.1 24200
3 EX-10.2 knsa-20220331xex10d2.htm EX-10.2 1459576
4 EX-10.3 knsa-20220331xex10d3.htm EX-10.3 1454675
5 EX-31.1 knsa-20220331xex31d1.htm EX-31.1 11326
6 EX-31.2 knsa-20220331xex31d2.htm EX-31.2 10482
7 EX-32.1 knsa-20220331xex32d1.htm EX-32.1 6289
8 EX-32.2 knsa-20220331xex32d2.htm EX-32.2 6263
9 GRAPHIC knsa-20220331xex10d2001.jpg GRAPHIC 9790
10 GRAPHIC knsa-20220331xex10d2002.jpg GRAPHIC 6888
11 GRAPHIC knsa-20220331xex10d2003.jpg GRAPHIC 8921
12 GRAPHIC knsa-20220331xex10d3002.jpg GRAPHIC 6888
13 GRAPHIC knsa-20220331xex10d3003.jpg GRAPHIC 8921
14 GRAPHIC knsa-20220331xex10d3001.jpg GRAPHIC 9790
  Complete submission text file 0001558370-22-007381.txt   10434646

Data Files

Seq Description Document Type Size
15 EX-101.SCH knsa-20220331.xsd EX-101.SCH 48220
16 EX-101.CAL knsa-20220331_cal.xml EX-101.CAL 48249
17 EX-101.DEF knsa-20220331_def.xml EX-101.DEF 242211
18 EX-101.LAB knsa-20220331_lab.xml EX-101.LAB 421468
19 EX-101.PRE knsa-20220331_pre.xml EX-101.PRE 347369
73 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20220331x10q_htm.xml XML 1087602
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 22896477
SIC: 2834 Pharmaceutical Preparations